NEOK Bio, Inc., a biotechnology company focused on the development of novel antibody drug conjugates (ADCs) for improving outcomes for cancer patients, announced that...
LambdaVision, a biotech innovator leveraging microgravity to manufacture its investigational protein-based artificial retina to help patients regain sight lost to retinal degenerative diseases, has...
Pinetree Therapeutics, a preclinical-stage biotechnology company pioneering targeted protein degraders for drug-resistant cancers, announced the successful closing of an oversubscribed $47 million Series B financing. The...
Plastomics, a cutting-edge leader in agricultural biotechnology, today announced the successful initial close of its Series B funding round, securing $5.8 million to fuel...
Hemab Therapeutics, a clinical-stage biotechnology company developing novel prophylactic therapeutics for serious, underserved bleeding and thrombotic disorders, today announced the completion of a multifold...
Faeth Therapeutics has successfully secured $25,000,000 in investment capital, marking a significant funding announcement for the biotechnology company. This injection of funds from investors...
Peptilogics, a clinical-stage biotechnology company developing transformative surgical therapeutics to effectively treat and prevent serious medical device infections, today announced the completion of an...
OncoC4, Inc. a clinical-stage biotechnology company, today announced the recent closing of a Series B financing round of nearly $50 million. The round was...
Aarvik Therapeutics, an innovative, ADC-focused biotechnology company dedicated to engineering precision medicines for cancer therapy, is pleased to announce that it has successfully closed...
FYR Bio, a biotechnology company leveraging extracellular vesicles (EVs) to create an end-to-end solution for new precision medicine tools, today announced it has closed...
